FGFR2-Rearranged Cholangiocarcinoma Highlights the Need for Precision Trial Design
Cholangiocarcinoma, a cancer arising in the bile ducts, has become an unexpected test of whether precision oncology can deliver on ...
Cholangiocarcinoma, a cancer arising in the bile ducts, has become an unexpected test of whether precision oncology can deliver on ...
KAIST researchers have reported a new class of T-cell-receptor-like antibodies designed to recognize an intracellular cancer mutation with high specificity. ...
As the landscape of precision cancer medicine continues to evolve, the integration of advanced data analytics and machine learning is ...
In the rapidly evolving field of medicine, artificial intelligence (AI) has emerged as a transformative force, particularly in computational pathology ...
In a groundbreaking advancement poised to reshape cancer therapy, scientists at the University of California San Diego have devised a ...
In the rapidly evolving field of oncology, the quest for more effective and personalized cancer treatments has reached a pivotal ...
Esophageal adenocarcinoma (EAC) represents one of the most formidable challenges in modern oncology, recognized as the sixth leading cause of ...
The advancement of precision oncology has become increasingly important as researchers seek to improve individualized treatment strategies for cancer patients. ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine